Literature DB >> 10751806

Mechanical Prosthetic Valve Thrombosis: Case Report and Review of the Literature.

.   

Abstract

Mechanical prosthetic valve thrombosis is a life-threatening complication necessitating immediate intervention. The presenting signs and symptoms of this illness are somewhat variable, but physical examination and transesophageal echocardiography enable rapid diagnosis. To avoid catastrophic complications, valve replacement or debridement, or thrombolysis in the correct setting, must be performed without delay. It is not entirely clear which therapy is superior. For any given patient, the risks of thrombolytic therapy, including bleeding, systemic embolism, and failure to restore valvular function, must be weighed against the risks of surgical intervention. Once the decision is made to operate, the choice of valve replacement versus debridement is one best made intraoperatively, upon visual inspection of the valve apparatus. Despite aggressive therapy, morbidity and mortality from prosthetic valve thrombosis and its treatment are not trivial. Fortunately, with current prosthetic devices and aggressive prophylactic anticoagulation, the incidence of prosthetic valve thrombosis remains low. Antiplatelet therapy may offer additional benefit to patients being prophylaxed with warfarin. This report details the case of a woman with aortic and mitral prosthetic valves who presented with heart failure and evidence of severe aortic prosthetic dysfunction after a period of suboptimal anticoagulation. She successfully underwent debridement of the mitral prosthesis and replacement of the aortic valve. The relevant literature is reviewed.

Entities:  

Year:  1998        PMID: 10751806     DOI: 10.1023/A:1008814614213

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  48 in total

1.  Thrombolytic therapy for prosthetic valve thrombosis: a study based on serial Doppler echocardiographic evaluation.

Authors:  R S Vasan; U Kaul; S Sanghvi; T Kamlakar; P C Negi; S Shrivastava; M Rajani; P Venugopal; H S Wasir
Journal:  Am Heart J       Date:  1992-06       Impact factor: 4.749

2.  The risk of thromboembolism following valvular operations: how does one know?

Authors:  D C McGoon
Journal:  J Thorac Cardiovasc Surg       Date:  1984-11       Impact factor: 5.209

3.  Ten to fifteen year reassessment of the performance characteristics of the Starr-Edwards Model 6120 mitral valve prosthesis.

Authors:  D C Miller; P E Oyer; E B Stinson; B A Reitz; S W Jamieson; W A Baumgartner; R S Mitchell; N E Shumway
Journal:  J Thorac Cardiovasc Surg       Date:  1983-01       Impact factor: 5.209

Review 4.  Thrombotic and bleeding complications of prosthetic heart valves.

Authors:  L H Edmunds
Journal:  Ann Thorac Surg       Date:  1987-10       Impact factor: 4.330

5.  Transesophageal echocardiography for the diagnosis and management of nonobstructive thrombosis of mechanical mitral valve prosthesis.

Authors:  P Gueret; P Vignon; P Fournier; J M Chabernaud; M Gomez; P LaCroix; J Bensaid
Journal:  Circulation       Date:  1995-01-01       Impact factor: 29.690

6.  Reoperations for left-sided low-profile mechanical prosthetic obstructions.

Authors:  J Martinell; J Fraile; V Artiz; J Cortina; P Fresneda; G Rábago
Journal:  Ann Thorac Surg       Date:  1987-02       Impact factor: 4.330

7.  Thrombolytic therapy for prosthetic cardiac valve thrombosis.

Authors:  S Kurzrok; A K Singh; A S Most; D O Williams
Journal:  J Am Coll Cardiol       Date:  1987-03       Impact factor: 24.094

Review 8.  Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses.

Authors:  S C Cannegieter; F R Rosendaal; E Briët
Journal:  Circulation       Date:  1994-02       Impact factor: 29.690

9.  Fibrinolytic treatment of thrombus on prosthetic heart valves.

Authors:  S Witchitz; C Veyrat; P Moisson; N Scheinman; L Rozenstajn
Journal:  Br Heart J       Date:  1980-11

10.  Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole.

Authors:  J H Chesebro; V Fuster; L R Elveback; D C McGoon; J R Pluth; F J Puga; R B Wallace; G K Danielson; T A Orszulak; J M Piehler; H V Schaff
Journal:  Am J Cardiol       Date:  1983-05-15       Impact factor: 2.778

View more
  1 in total

1.  How to perform and manage low-dose and slow/ultra-slow tissue type plasminogen activator infusion regimens in patients with prosthetic valve thrombosis.

Authors:  Ahmet Guner; Macit Kalcik; Mustafa Ozan Gursoy; Sabahattin Gunduz; Mehmet Ozkan
Journal:  J Thromb Thrombolysis       Date:  2018-10       Impact factor: 2.300

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.